Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population

Journal of Clinical Hypertension

Volumn 20, Issue 1, 2018, Pages 88-95

  Dixon, Dave L ^a   Sisson, Evan M ^a   Parod, Eric D ^a   Van Tassell, Benjamin W ^a   Nadpara, Pramit A ^a   Carl, Daniel ^b   W Dow, Alan ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL OUTCOME; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MALE; MEDICAL RECORD; MIDDLE AGED; PATIENT CARE; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BLOOD PRESSURE MEASUREMENT; INTERSECTORAL COLLABORATION; LONGITUDINAL STUDY; MEDICALLY UNINSURED; MEDICATION THERAPY MANAGEMENT; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; PATIENT CARE PLANNING; PROCEDURES; TOTAL QUALITY MANAGEMENT; UNITED STATES;

ADULT; BLOOD PRESSURE DETERMINATION; FEMALE; HUMANS; HYPERTENSION; INTERSECTORAL COLLABORATION; LONGITUDINAL STUDIES; MALE; MEDICALLY UNINSURED; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; MODELS, ORGANIZATIONAL; PATIENT CARE PLANNING; PATIENT CARE TEAM; PHARMACISTS; PHYSICIANS; QUALITY IMPROVEMENT; UNITED STATES;

EID: 85038033601     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.13150     Document Type: Article

References (28)

1. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e1-e485.
2. Egan BM, Li J, Small J, Nietert PJ, Sinopoli A. The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010. Hypertension. 2014;64:997-1004.
3. Gu A, Yue Y, Desai RP, Argulian E. Racial and ethnic differences in antihypertensive medication use and blood pressure control among US adults with hypertension. Circ Cardiovasc Qual Outcomes. 2017;10:e003166.
4. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults. JAMA. 2014;311:507-520.
5. Lebeau JP, Cadwallader JS, Aubin-Auger I, et al. The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review. BMC Fam Pract. 2014;15:130.
6. Xu W, Goldberg SI, Shubina M, Turchin A. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study. BMJ. 2015;350:h158.
7. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022-2031.
8. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169:1748-1755.
9. Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens (Greenwich). 2012;14:51-65.
10. Brush JE, Handberg EM, Biga C, et al. 2015 ACC health policy statement on cardiovascular team-based care and the role of advanced practice providers. J Am Coll Cardiol. 2015;65:2118-2136.
11. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2015;310:952-967.
12. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control. JAMA. 2008;299:2857-2867.
13. Giberson S, Yoder SLM. Improving patient and health system outcomes through advanced pharmacy practice. A Report to the U.S. Surgeon General. Office of the Chief Pharmacist [serial online]. 2011. https://www.accp.com/docs/positions/misc/Improving_Patient_and_Health_System_Outcomes.pdf. Accessed August 1, 2017.
14. Centers for Disease Control and Prevention. Using the pharmacists’ patient care process to manage high blood pressure: a resource guide for pharmacists [serial online]. 2016. https://www.cdc.gov/dhdsp/pubs/docs/pharmacist-resource-guide.pdf. Accessed May 30, 2017.
15. Centers for Disease Control and Prevention. Methods and resources for engaging pharmacy partners [serial online]. 2016. https://www.cdc.gov/dhdsp/pubs/docs/engaging-pharmacy-partners-guide.pdf. Accessed May 30, 2017.
16. Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3:e000718-e000718.
17. Anderegg MD, Gums TH, Uribe L, Coffey CS, James PA, Carter BL. Physician-pharmacist collaborative management: narrowing the socioeconomic blood pressure gap. Hypertension. 2016;68:1314-1320.
18. Carter BL, Coffey CS, Ardery G, et al. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8:235-243.
19. Sisson EM, Dixon DL, Kildow DC, et al. Effectiveness of a pharmacist-physician team-based collaboration to improve long-term blood pressure control at an inner-city safety-net clinic. Pharmacotherapy. 2016;36:342-347.
20. McBane SE, Dopp AL, Abe A, et al. Collaborative drug therapy management and comprehensive medication management-2015. Pharmacotherapy. 2015;35:e39-e50.
21. Retchin SM, Gartand SL, Anum EA. The transfer of uninsured patients from academic to community primary care settings. Am J Manag Care. 2009;15:245-252.
22. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47:345-351.
23. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
24. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy. 2001;21:1337-1344.
25. Polgreen LA, Han J, Carter BL, et al. Cost effectiveness of a physician-pharmacist collaboration intervention to improve blood pressure control. Hypertension. 2015;66:1145-1151.
26. Burgess SE, MacLaughlin EJ, Smith PA, Salcido A, Benton TJ. Blood pressure rising: differences between current clinical and recommended measurement techniques. J Am Soc Hypertens. 2011;5:484-488.
27. Graves JW, Sheps SG. Does evidence-based medicine suggest that physicians should not be measuring blood pressure in the hypertensive patient? Am J Hypertens. 2004;17:354-360.
28. Minor DS, Butler KR, Artman KL, et al. Evaluation of blood pressure measurement and agreement in an academic health sciences center. J Clin Hypertens (Greenwich). 2012;14:222-227.